Cite
HARVARD Citation
Capodanno, D. et al. (2016). Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10, 350 patients from five randomized clinical trials. European heart journal. 5 (3), pp. 253-262. [Online].